✦ LIBER ✦

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

✍ Scribed by Afdhal, Nezam; Reddy, K. Rajender; Nelson, David R.; Lawitz, Eric; Gordon, Stuart C.; Schiff, Eugene; Nahass, Ronald; Ghalib, Reem; Gitlin, Norman; Herring, Robert; Lalezari, Jacob; Younes, Ziad H.; Pockros, Paul J.; Di Bisceglie, Adrian M.; Arora, Sanjeev; Subramanian, G. Mani; Zhu, Yanni; Dvory-Sobol, Hadas; Yang, Jenny C.; Pang, Phillip S.; Symonds, William T.; McHutchison, John G.; Muir, Andrew J.; Sulkowski, Mark; Kwo, Paul

Book ID: 121825176
Publisher: Massachusetts Medical Society
Year: 2014
Tongue: English
Weight: 525 KB
Volume: 370
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1316366

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ledipasvir and Sofosbuvir for Untreated

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

✍ Afdhal, Nezam; Zeuzem, Stefan; Kwo, Paul; Chojkier, Mario; Gitlin, Norman; Puoti 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 436 KB

Boceprevir for Previously Treated Chroni

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

✍ Bacon, Bruce R.; Gordon, Stuart C.; Lawitz, Eric; Marcellin, Patrick; Vierling, 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 623 KB

764 Sofosbuvir/Ledipasvir With and Witho

764 Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study

✍ Kowdley, Kris V.; Gordon, Stuart C.; Reddy, K. Rajender; Rossaro, Lorenzo; Berns 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 166 KB

O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHO

O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHOUT RIBAVIRIN FOR 8 WEEKS COMPARED TO SOFOSBUVIR/LEDIPASVIR FOR 12 WEEKS IN TREATMENT-NAÏVE NON-CIRRHOTIC GENOTYPE-1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-3 STUDY

✍ Kowdley, K.V.; Stuart, G.C.; Reddy, R.K.; Rossaro, L.; Bernstein, D.E.; An, D.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 172 KB

O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED D

O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION FOR TREATMENT OF HCV GENOTYPE-1 IN PATIENTS COINFECTED WITH HIV

✍ Osinusi, A.; Townsend, K.; Nelson, A.; Kohli, A.; Gross, C.; Polis, M.A.; Pang, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Efficacy of Nucleotide Polymerase Inhibi

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection

✍ Gane, Edward J.; Stedman, Catherine A.; Hyland, Robert H.; Ding, Xiao; Svarovska 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 585 KB